Nebraska Reportable Disease Surveillance
GUIDE TO REPORTABLE DISEASES, POISONINGS, ORGANISMS, AND EVENTS
Acinetobacter spp., ‡
Acquired Immunodeficiency Syndrome (AIDS)
Adenovirus infection (conjunctivitis, respiratory)
Amebae-associated infection (Acanthamoeba spp., Entamoeba histolytica, and
Naegleria fowleri
Anthrax (Bacillus anthracis^)* ‡
Arboviral infections (including but not limited West Nile virus, St. Louis
encephalitis virus, Western Equine Encephalitis virus, and Dengue virus)*
Babesiosis (Babesia species)
Botulism (Clostridium botulinum^)*
Brucellosis (Brucella abortus^, B. melitensis^, and B. suis^*‡
Campylobacteriosis (Campylobacter^ species) ‡
Carbon monoxide poisoning (use breakpoint for non-smokers)
Chancroid (Haemophilus ducreyi ) ‡±
Chlamydia trachomatis infections ‡±
Cholera (Vibrio cholerae^) ‡
Clostridium difficile
Clusters, Outbreaks, or Unusual Events, Including Possible Bioterroristic
Attacks*
Coccidiodomycosis (Coccidioides immitis/posodasiI^)*
Creutzfeldt-Jakob Disease (subacute spongiform encephalopathy
Cryptosporidiosis (Cryptosporidium parvum)
Cyclosporiasis (Cyclospora cayetanensis)
Diphtheria (Corynebacterium diphtheriae) ‡
Eastern equine encephalitis (EEE virus^)*
Ehrlichiosis, human granulocytic (Ehrlichia phagocytophila)
Ehrlichiosis, human monocytic (Ehrlichia chaffeenis) ‡
Encephalitis (caused by viral agents)
Enterococcus spp. ‡
Escherichia coli gastroenteritis (E. coli O157-H7^ and other Shigatoxin-positive E.
coli from gastrointestinal infection^)
Food poisoning, outbreak-associated
Giardiasis (Giardia lamblia)
Glanders [Burkholderia (Pseudomonas) mallei^]* ‡
Gonorrhea (Neisseria gonorrhoeae): venereal infection and ophthalmia
neonatorum ‡±
Haemophilus influenzae infection (invasive disease only)^ ‡
Hansen’s Disease (Leprosy [Mycobacterium leprae]) ‡
Hantavirus pulmonary syndrome (Sin Nombre virus)
Hemolytic uremic syndrome (post-diarrheal illness)
Hepatitis A (IgM antibody-positive or clinically diagnosed during an
outbreak)
Hepatitis B infection (positive surface antigen tests and all IgM core antibody
tests, both positive and negative) ±
Hepatitis C infection (all positive screening tests to include signal-to-cutoff ratio
[S:CO] are reportable; all confirmatory tests are reportable regardless of
result)
Hepatitis D and E infection
Herpes simplex, primary genital infection ±
Histoplasmosis (Histoplasma capsulatum)
Human immunodeficiency virus infection
Influenza (Antigen or PCR positive or culture confirmed)
Influenza deaths, pediatric (< 18 years of age)
Influenza due to novel or pandemic strains (includes highly pathogenic
avian influenza virus^)*
Influenza, all tests (applies only to laboratories performing electronic lab
reporting as specified in 173 NAC 1-005.02C)
Influenza, rapid tests summary report only (laboratories only)
Kawasaki disease (mucocutaneous lymph node syndrome)
Klebsiella sp., ‡
Lead poisoning (all analytical values for blood lead analysis)
Malaria (Plasmodium species)
Measles (Rubeola)
Melioidosis [Burkholderia (Pseudomonas) pseudomallei]* ‡
Meningitis (Haemophilus influenzae^ or Neisseria meningitidis^)
Meningitis, viral, bacterial, and fungal
Meningococcal disease, invasive (Neisseria meningitidis^)
Methemoglobinemia / nitrate poisoning (methemoglobin greater than 5% of
total hemoglobin)
Monkeypox virus infection*
Mumps
Mycobacteria spp. (M. tuberculosis complex organisms^ and all “atypical” species
indicative of tuberculosis infection or disease) ‡
Necrotizing fasciitis
Norovirus infection (laboratories only)
Pertussis [whooping cough] (Bordetella pertussis^) ‡
Plague (Yersinia pestis^)* ‡
Poisoning or illness due to exposure to agricultural chemicals, industrial
chemicals, mercury, or radiologic exposures
Poliomyelitis, paralytic
Q fever (Coxiella burnetii^)* ‡
Rabies (human and animal cases and suspects)
Respiratory syncytial virus infection (laboratories only)
Retrovirus infections (other than HIV)
Rheumatic fever, acute (cases meeting the Jones criteria only)
Ricin poisoning*
Rift Valley fever*
Rocky Mountain Spotted Fever (Rickettsia rickettsii^)*
Rotavirus infection ([all positive and negative tests] applies only to laboratories
performing electronic lab reporting as described in 173 NAC 1-005.02C
Rubella and congenital rubella syndrome
Salmonellosis, including typhoid fever (Salmonella serogroup^) ‡
Severe Acute Respiratory Syndrome [SARS] (SARS-associated coronavirus)
Shiga toxin-positive gastroenteritis (enterohemorrhagic E. coli and other shiga
toxin-producing bacteria^)
Shigellosis (Shigella species^) ‡
Smallpox*
Staphylococcal enterotoxin B intoxication* ‡
Staphylococcus aureus (applies only to laboratories performing electronic lab
reporting as specified in 1-005.02C)
Staphylococcus aureus, vancomycin-intermediate/resistant (MIC > 4
µg/mL) ‡
Streptococcal disease (all invasive disease caused by Groups A and B
streptococci) ‡
Streptococcus pneumoniae, all isolates ‡
Syphilis (Treponema pallidum) RPR and FTA reactive ±
Syphilis, congenital
Tetanus (Clostridium tetani) ‡
Tick-borne encephalitis, virus complexes (Central European Tick-borne
encephalitis virus, Far Eastern Tick-borne encephalitis virus, Kyasanur
Forest disease virus, Omsk Hemorrhagic Fever virus, Russian Spring and
Summer encephalitis virus)*
Toxic shock syndrome
Toxoplasmosis, acute (Toxoplasma gondii)
Transmissible spongiform encephalopathies
Trichinosis (Trichinella spiralis)
Tuberculosis (see Mycobacteria)
Tularemia (Francisella tularensis^)*‡
Typhus Fever, louse-borne (Rickettsia prowazekii^)* and flea-borne /
endemic murine (Rickettsia typhi)
Varicella death (all ages)
Varicella primary infections (chicken pox)
Legionellosis (Legionella species) ‡
Leptospirosis (Leptospira interrogans)
Listeriosis (Listeria monocytogenes^) ‡
Lyme disease (Borrelia burgdorferi)
Lymphocytic choriomeningitis virus infection
Lymphogranuloma venereum (LGV [Chlamydia trachomatis]) ±
Venezuelan equine encephalitis*
Viral hemorrhagic fever (including but not limited to Ebola virus, Marburg
virus, and Lassa fever virus)*
Yellow Fever
Yersiniosis (Yersinia species not Y. pestis) ‡
Bold Type: Report immediately | Plain Type: Report within seven days
* Potential agents of bioterrorism (designated as select agents by CDC)
^ Laboratories must submit the isolate and/or specimen to the Nebraska Public Health Laboratory as specified in 173 NAC 1-007.03.
‡ Laboratories performing electronic lab reporting as specified in 173 NAC 1-005.02C must report any antibiotic susceptibility test results
± STD in accordance with Neb. Rev. Stat. § 71-502.01.
Nebraska Department of Health and Human Services, Office of Epidemiology, PO Box 95026, NE 68509, Phone 402-471-2937 Fax 402-471-3601.
1-004.04 Reporting of Antibiotic Susceptibility: All laboratories reporting via automated
electronic laboratory reporting (ELR) must report all antimicrobial susceptibility results, if
performed for bacterial isolates listed in 173 NAC 1-004.01 and 1-004.02 (indicated by a ‡).
Laboratories not reporting via automated ELR are exempt from this requirement.
Reportable Diseases – Nebraska 2014
Confirmed and Probable Cases by Condition and Year, Nebraska
CONDITION
Amebiasis
Anaplasma phagocytophilum
Animal Exposure (bite or nonbite)
Aseptic meningitis
Babesiosis
Bacterial meningitis, other
Botulism (infant)
Brucellosis
Campylobacteriosis
Chlamydia trachomatis infection
Coccidioidomycosis
Cryptosporidiosis
Cyclosporiasis
Dengue Fever
Ehrlichiosis, Human, other & unspecified
Ehrlichiosis, chaffeensis
Encephalitis primary, other
Giardiasis
Group A Streptococcus, invasive
Group B Streptococcus, invasive
Haemophilus influenzae, invasive
Hansen disease (Leprosy)
Hemolytic uremic syndrome, post-diarrheal
Hepatitis A, acute
Hepatitis B virus infection, chronic
Hepatitis B, acute
2014 YTD
1
0
113
11
0
3
0
0
69
2
1
17
0
0
0
0
3
34
22
34
6
0
0
2
62
2
2013 YTD
1
0
70
8
0
1
1
1
81
0
0
21
0
0
0
0
0
47
10
17
9
0
0
5
72
5
2013 Total
15
2
722
108
1
7
1
3
482
0
1
155
91
1
1
6
1
177
33
92
31
1
3
15
238
16
2012 Total
7
2
452
133
1
8
0
0
467
0
1
163
0
3
0
0
1
200
29
73
31
0
1
17
197
7
CONDITION
Hepatitis C Virus Infection, chronic or resolved
Hepatitis C, acute
Hepatitis Delta co- or super-infection, acute
Histoplasmosis
Influenza Outbreak
Influenza, human isolates
Kawasaki disease
Lead poisoning (Adult)
Lead poisoning (Child)
Legionellosis
Listeriosis
Lyme disease
Malaria
Mumps
Mycobacterium Avium
Mycobacterium, non-TB (organism)
Necrotizing fasciitis
Neisseria meningitidis, invasive (Mening. disease)
Noroviruses
Pertussis
Psittacosis (Ornithosis)
Q fever, Acute
Q fever, Chronic
RSV
Rabies, animal
Rheumatic fever (Acute)
Rotavirus
S. aureus, coag+, meth- or oxi- resistant (MRSA)
Salmonella
Salmonellosis
Shiga toxin-producing Escherichia coli (STEC)
Shigellosis
Spotted Fever Rickettsiosis
Strep pneumoniae, invasive
Strep, other, invasive, beta-hem (non-A nonB)
Streptococcal toxic-shock syndrome
Streptococcus pneumoniae, invasive disease (IPD)
Trichinosis (Trichinellosis)
Tuberculosis
Tuberculosis LTBI - Latent Infection
Tularemia
Vancomycin-Resistant Enterococcus
Varicella (Chickenpox)
Vibrio parahaemolyticus (non-Cholera)
Vibrio sp., non-toxigenic, other/unspecified
Vibriosis (non-cholera Vibrio species infections)
West Nile Fever
West Nile, Encephalitis/meningitis
Yersiniosis (not Plague)
2014 YTD
285
1
1
3
0
20
2
79
5
1
0
3
0
0
9
13
0
0
106
64
0
0
0
80
4
0
0
0
0
29
9
11
0
0
2
0
53
0
6
0
0
1
4
0
0
0
2
0
1
2013 YTD
360
1
0
8
1
503
0
0
1
11
0
0
1
0
7
14
0
3
58
45
0
0
1
239
10
1
0
2
0
55
8
15
0
1
1
0
63
0
4
0
1
0
6
0
0
0
4
2
2
2013 Total
1,093
2
1
20
1
532
4
6
30
22
2
10
7
0
14
34
1
5
113
244
1
4
5
250
34
1
0
4
0
309
81
71
17
3
3
0
169
1
23
6
17
1
25
3
0
0
179
55
7
2012 Total
942
2
0
72
0
587
9
0
3
13
4
12
4
1
24
35
0
3
68
242
0
3
3
86
60
1
30
2
2
358
109
279
8
1
3
1
147
1
23
0
6
0
40
0
1
1
146
43
3